# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k151771   
B. Purpose for Submission: New device   
C. Measurand: Benzodiazepines   
D. Type of Test: Qualitative and semi-quantitative homogeneous enzyme immunoassay   
E. Applicant: Immunalysis Corporation   
F. Proprietary and Established Names: Immunalysis Benzodiazepines Urine Enzyme Immunoassay Immunalysis Multi-Drug Calibrators

G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>JXM  Benzodiazepine testsystem</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR §862.3170</td><td rowspan=1 colspan=1>91 - Toxicology</td></tr><tr><td rowspan=1 colspan=1>DKB - Clinical ToxicologyCalibrator</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR §862.3200</td><td rowspan=1 colspan=1>91 - Toxicology</td></tr></table>

# H. Intended Use:

1. Intended use(s): See Indication(s) for use below.

2. Indication(s) for use:

The Immunalysis Benzodiazepine Urine Enzyme Immunoassay is a homogeneous enzyme immunoassay with a cutoff of $2 0 0 \mathrm { n g / m L }$ . The assay is intended for use in laboratories for the qualitative and semi-quantitative analysis of Benzodiazepine in human urine with automated clinical chemistry analyzers. This assay is calibrated against Oxazepam. This in-vitro device is for prescription use only.

The semi-quantitative mode is for purposes of enabling laboratories to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as Gas Chromatography/ Mass Spectrometry (GC-MS) or permitting laboratories to establish quality control procedures.

The Immunalysis Benzodiazepine Urine Enzyme Immunoassay Kit provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC-MS or Liquid Chromatography / Mass Spectrometry (LC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

# Immunalysis Multi-Drug Calibrators

The Immunalysis Multi-Drug Calibrators are intended for in vitro diagnostic use for the calibration of assays for the analytes currently listed in the package insert: Benzoylecgonine, Morphine and Oxazepam. The calibrators are designed for prescription use with immunoassays.

3. Special conditions for use statement(s): For prescription use only.

4. Special instrument requirements: Performance data was obtained using the Beckman AU400e clinical chemistry analyzer.

# I. Device Description:

The Immunalysis Benzodiazepine Urine Enzyme Immunoassay Kit contains two reagents, which are provided as ready-to-use:

Antibody/Substrate Reagent (RA) – This reagent contains monoclonal antibodies to Benzodiazepines, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with Sodium Azide as a preservative.   
Enzyme Conjugate Reagent (RE) – This reagent contains benzodiazepines derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in HEPES buffer with Sodium Azide as a preservative.

The Immunalysis Multi-Drug Calibrators set is liquid and ready-to-use. The negative calibrator is a processed, drug-free synthetic urine matrix with sodium azide as a preservative. Each calibrator level contains a known concentration of oxazepam spiked into the negative calibrator matrix.

# J. Substantial Equivalence Information:

1. Predicate device name(s):

DRI® Benzodiazepines Assay LZI Multiple Analyte Drugs of Abuse Calibrators and Controls

2. Predicate 510(k) number(s):

k930529   
k051088

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=2>Candidate Device                Predicate  k930529</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>For the qualitative andsemiquantitativedetermination of the presenceof Benzodiazepines in humanurine at a cutoff of 200 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Homogeneous EnzymeImmunoassay</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>200 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Reagent Form</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Liquid Ready-to-Use TwoReagent Assay</td></tr><tr><td rowspan=1 colspan=1>Reagent Storage</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>2-8°C</td></tr></table>

<table><tr><td colspan="3">Differences</td></tr><tr><td>Item</td><td>Candidate Device</td><td>Predicate  k930529</td></tr><tr><td>Antibody</td><td>Monoclonal antibodies to Benzodiazepines</td><td>Sheep polyclonal antibody to Benzodiazepine</td></tr><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="2" rowspan="1">Candidate Device                Predicate - k051088</td></tr><tr><td colspan="1" rowspan="1">Analyte</td><td colspan="1" rowspan="1">Benzoylecgonine,morphine, oxazepam</td><td colspan="1" rowspan="1">Benzoylecgonine, d-methamphetamine,methadone, morphine,oxazepam, secobarbital,phencyclidine andpropoxyphene</td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Urine</td></tr><tr><td colspan="1" rowspan="1">Calibrator Levels</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">5 levels</td></tr><tr><td colspan="1" rowspan="1">Storage</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">2-8</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

• CLSI EP5-A2, Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline—Second Edition   
• CLSI EP7-A2, Interference Testing in Clinical Chemistry; Approved Guideline—Second Edition

# L. Test Principle:

The assay is based on the competition of Oxazepam labeled enzyme glucose-6-phosphate dehydrogenase (G6PDH) and the free drug in the urine sample for the fixed amount of antibody binding sites. In the absence of the free drug in the sample, the antibody binds the drug enzyme conjugate and enzyme activity is inhibited. This creates a dose response relationship between drug concentration in the urine sample and enzyme activity. The enzyme G6PDH activity is determined at $3 4 0 \mathrm { n m }$ spectrophotometrically by the conversion of NAD to NADH.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

A precision/cutoff characterization study was performed for 20 days, 2 runs per day in duplicate $( \mathrm { N } { = } 8 0 )$ ) on drug-free negative urine samples spiked with oxazepam to concentrations of $\pm 2 5 \%$ , $\pm 5 0 \%$ , $\pm 7 5 \%$ , and $\pm 1 0 0 \%$ of each cutoff. The spiked concentrations were confirmed by mass spectrometry (MS). The results of the study are summarized below:

<table><tr><td rowspan=1 colspan=4>Qualitative Analysis</td></tr><tr><td rowspan=1 colspan=1>Concentration (ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1># of determinations</td><td rowspan=1 colspan=1>Result</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg / 0 Pos</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg/ 0 Pos</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg/ 0 Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg/0 Pos</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>37 Neg/43 Pos</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos/0 Neg</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos/0 Neg</td></tr><tr><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos/0 Neg</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos / 0 Neg</td></tr></table>

<table><tr><td rowspan=1 colspan=4>Semi-quantitative Analysis</td></tr><tr><td rowspan=1 colspan=1>Concentration (ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1># of determinations</td><td rowspan=1 colspan=1>Result</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg / 0 Pos</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg/ 0 Pos</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg/0 Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Neg/0 Pos</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>34 Neg46 Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos0 Neg</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos0 Neg</td></tr><tr><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos0 Neg</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Pos/0 Neg</td></tr></table>

# $b$ . Linearity/assay reportable range:

A linearity study in the semi-quantitative mode was conducted by spiking a drug-free urine pool with a high concentration of oxazepam and generating serial dilutions to achieve concentrations ranging from $1 0 0 ~ \mathrm { { n g / m L } }$ to $1 1 0 0 ~ \mathrm { { n g / m L } }$ . Each concentration was tested in triplicate and drug recovery calculated using the mean concentration of the replicates. The results are summarized below:

<table><tr><td colspan="3" rowspan="1">Linearity/Recovery</td></tr><tr><td colspan="1" rowspan="1">Expected Concentration(ng/mL)</td><td colspan="1" rowspan="1">Mean Concentration(ng/mL)</td><td colspan="1" rowspan="1">Recovery (%)</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">94.2</td><td colspan="1" rowspan="1">94.2</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">213.7</td><td colspan="1" rowspan="1">106.8</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">313.9</td><td colspan="1" rowspan="1">104.6</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">389.7</td><td colspan="1" rowspan="1">97.4</td></tr><tr><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">511.6</td><td colspan="1" rowspan="1">102.3</td></tr><tr><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">637.2</td><td colspan="1" rowspan="1">106.2</td></tr><tr><td colspan="1" rowspan="1">700</td><td colspan="1" rowspan="1">693.2</td><td colspan="1" rowspan="1">99.0</td></tr><tr><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">820.7</td><td colspan="1" rowspan="1">102.6</td></tr><tr><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1">907.6</td><td colspan="1" rowspan="1">100.8</td></tr><tr><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">1025.3</td><td colspan="1" rowspan="1">102.5</td></tr><tr><td colspan="1" rowspan="1">1100</td><td colspan="1" rowspan="1">1061.1</td><td colspan="1" rowspan="1">96.5</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Traceability

The analyte in the calibrator is traceable to a commercially available oxazepam solution. This standard is diluted with synthetic negative urine to make the calibrator s to the desired concentrations. The concentrations are confirmed by Gas Chromatography/Mass Spectrometry Analysis (GC/MS) and/or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS).

Value Assignment/Expected Values

The Negative Calibrator is a processed, drug free urine matrix. The standard is compared to a reference negative standard to ensure that it is free of analyte. A value is assigned when the test is within the acceptable range.

The non-zero calibrators are prepared by spiking known concentrations of oxazepam into the negative calibrator matrix. The concentrations are confirmed by GC/MS or LC/MS/MS. If any of the analytes are out of the acceptable range, then the calibrator is adjusted and re-tested. Values are assigned to the calibrator once the GC/MS or LC/MS/MS results are within the acceptable range.

# Calibrator Stability

Closed-vial accelerated stability and open vial stability studies were conducted for the calibrators. Real-time stability studies are ongoing. All stability protocols were reviewed and found to be acceptable. These studies support the closed vial stability claim of 12 months and the opened vial stability claim of 60 days when calibrators are stored at $2 { - } 8 ^ { \circ } \mathrm { C }$ .

d. Detection limit: Not applicable.

e. Analytical specificity:

Structurally related compounds

The sponsor performed cross-reactivity studies in both qualitative and semiquantitative modes by spiking various benzodiazepines or structurally related compounds into drug free urine at levels that will yield a result that is equivalent to the assay cutoff $( 2 0 0 ~ \mathrm { n g / m L } )$ . The results were the same for the qualitative and semiquantitative modes and are summarized below:

<table><tr><td rowspan=1 colspan=3>Structurally Related Compounds Qualitative &amp; Semi-quantitative</td></tr><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Lowest ConcentrationProducing a Positive Result(ng/mL)</td><td rowspan=1 colspan=1>% Cross-reactivity</td></tr><tr><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>Alpha-hydroxyalprazolam</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>181.8</td></tr><tr><td rowspan=1 colspan=1>Alprazolam</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>166.7</td></tr><tr><td rowspan=1 colspan=1>7-Aminoclonazepam</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt; 0.002</td></tr><tr><td rowspan=1 colspan=1>7-Aminoflunitrazepam</td><td rowspan=1 colspan=1>3,500</td><td rowspan=1 colspan=1>5.7</td></tr><tr><td rowspan=1 colspan=1>7-Aminonitrazepam</td><td rowspan=1 colspan=1>35,000</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>Bromazepam</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>26.7</td></tr><tr><td rowspan=1 colspan=1>Chlordiazepoxide</td><td rowspan=1 colspan=1>1,600</td><td rowspan=1 colspan=1>12.5</td></tr><tr><td rowspan=1 colspan=1>Clorazepate</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>Clobazam</td><td rowspan=1 colspan=1>650</td><td rowspan=1 colspan=1>30.8</td></tr><tr><td rowspan=1 colspan=1>Clonazepam</td><td rowspan=1 colspan=1>180</td><td rowspan=1 colspan=1>111.1</td></tr><tr><td rowspan=1 colspan=1>Demoxepam</td><td rowspan=1 colspan=1>5,500</td><td rowspan=1 colspan=1>3.6</td></tr><tr><td rowspan=1 colspan=1>Desalkyflurazepam</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>266.7</td></tr><tr><td rowspan=1 colspan=1>Diazepam</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>200.0</td></tr><tr><td rowspan=1 colspan=1>Estazolam</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>88.9</td></tr><tr><td rowspan=1 colspan=1>Flunitrazepam</td><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>160.0</td></tr><tr><td rowspan=1 colspan=1>Flurazepam</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>181.8</td></tr><tr><td rowspan=1 colspan=1>Lorazepam</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>333.3</td></tr><tr><td rowspan=1 colspan=1>Lorazepam glucuronide</td><td rowspan=1 colspan=1>180</td><td rowspan=1 colspan=1>111.1</td></tr><tr><td rowspan=1 colspan=1>Lormetazepam</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>400.0</td></tr><tr><td rowspan=1 colspan=1>Medazepam</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>40.0</td></tr><tr><td rowspan=1 colspan=1>Midazolam</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>500.0</td></tr><tr><td rowspan=1 colspan=1>Nitrazepam</td><td rowspan=1 colspan=1>700</td><td rowspan=1 colspan=1>28.6</td></tr><tr><td rowspan=1 colspan=1>Norchlordiazepoxide</td><td rowspan=1 colspan=1>2,200</td><td rowspan=1 colspan=1>9.1</td></tr><tr><td rowspan=1 colspan=1>Nordiazepam</td><td rowspan=1 colspan=1>180</td><td rowspan=1 colspan=1>111.1</td></tr><tr><td rowspan=1 colspan=1>Oxazepam glucuronide</td><td rowspan=1 colspan=1>1,300</td><td rowspan=1 colspan=1>15.4</td></tr><tr><td rowspan=1 colspan=1>Prazepam</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>210.5</td></tr><tr><td rowspan=1 colspan=1>Temazepam</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>181.8</td></tr><tr><td rowspan=1 colspan=1>Temazepam glucuronide</td><td rowspan=1 colspan=1>700</td><td rowspan=1 colspan=1>28.6</td></tr><tr><td rowspan=1 colspan=1>Triazolam</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>400.0</td></tr></table>

Potential interference from non-structurally related drugs and metabolites was evaluated in the qualitative and semi-quantitative modes by spiking these compounds into drug free urine containing oxazepam $a \mathbf { t } \pm 2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff (150 $\mathrm { n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ respectively). The results were the same for the qualitative and semi-quantitative modes and are summarized below:

<table><tr><td colspan="4" rowspan="1">Structurally Unrelated Compounds</td></tr><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Concentration Tested(ng/mL )</td><td colspan="1" rowspan="1">-25% Cutoff(150 ng/mL)</td><td colspan="1" rowspan="1">+25% Cutoff(250 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">4-Bromo-2,5,Dimethoxyphenethylamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">6-Acetylcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic Acid</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">S-(+) Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzylpiperazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Bupropion</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Butabarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">cis-Tramadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carisoprodol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cotinine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Delta-9-THC</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">N-desmethyltapentadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">1R,2S(-)-Ephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">1S,2R(+)-Ephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ethyl β-D-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hexobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">11-hydroxy-delta-9-THC</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Lamotrigine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Levorphanol Tartrate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Lidocaine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">LSD</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">(+)-MDA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">MDEA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">MDMA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">S(+)-Methamphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methaquolone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-6-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norpseudoephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">PCP</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Pentazocine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenylephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenylpropanolamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenytoin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">PMA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Propranolol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">R,R(-)-Pseudoephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">S,S(+)-Pseudoephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ranitidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ritalinic Acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Salicylic Acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Sertraline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Sufentanil Citrate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">11-nor-9carboxy THC</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Theophylline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Trifluoromethylphenyl-piperazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Zolpidem Tartrate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr></table>

# Endogenous compounds

Potential interference from endogenous compounds was evaluated in the qualitative and semi-quantitative modes by spiking these compounds into drug free urine containing oxazepam $3 t \pm 2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff $( 1 5 0 \mathrm { n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ , respectively). The results were the same for the qualitative and semi-quantitative modes and are summarized below:

<table><tr><td rowspan=1 colspan=4>Endogenous Compounds</td></tr><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>ConcentrationTested(ng/mL)</td><td rowspan=1 colspan=1>-25% Cutoff(150 ng/mL)</td><td rowspan=1 colspan=1>+25% Cutoff(250ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>1.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>0.002 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>0.01 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>γ-Globulin</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>0.115 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Human Serum Albumin</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>0.1 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>0.0075 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Sodium Azide</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>SodiumChloride</td><td rowspan=1 colspan=1>6.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>SodiumFluoride</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>6.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr></table>

Boric Acid. Boric Acid was also evaluated. Boric Acid at a concentration of $1 \% \mathrm { w / v }$ was found to cause false negative results at $+ 2 5 \%$ and $+ 5 0 \%$ ( $2 5 0 ~ \mathrm { n g / m L }$ and 300 $\mathrm { n g / m L }$ , respectively) at the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff in both the qualitative and semiquantitative modes and the following statement is provided in the limitations

section of the labeling: “Boric Acid at $1 \% w \%$ may cause false negative results. Boric Acid is not recommended as a preservative for urine”.

# pH and Specific Gravity

To evaluate potential interference from the $\mathsf { p H }$ of urine, device performance in the qualitative and semi-quantitative modes was tested using a range of urine $\mathsf { p H }$ values (3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0 and 11.0). All test samples were prepared in drug free urine containing oxazepam at $\pm 2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff $\mathrm { 1 5 0 n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ , respectively). No positive or negative interference was observed at urine $\mathsf { p H }$ values ranging from 3.0 to 11.0 for each test mode.

To evaluate potential interference from the specific gravity of urine, device performance in the qualitative and semi-quantitative modes was tested using a range of urine specific gravity values (1.000, 1.002, 1.005, 1.010, 1.015, 1.020, 1.025 and 1.030). All test samples were prepared in drug free urine containing oxazepam at $\pm$ $2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff ( $1 5 0 ~ \mathrm { n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ , respectively). No positive or negative interference was observed at urine specific gravity values ranging from 1.000 to 1.030 for each test mode.

$f .$ Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentrations of $2 0 0 ~ \mathrm { { n g / m L } }$ is described in the precision section, M.1.a. above.

2. Comparison studies:

# a. Method comparison with predicate device:

Eighty-six unaltered urine samples from clinical testing laboratories were analyzed for Benzodiazepine by the candidate device on the Beckman Coulter AU400e clinical chemistry analyzer and with LC/MS. The results were identical in both qualitative and semi-quantitative modes and are summarized below:

<table><tr><td rowspan=1 colspan=1>CandidateDevice Results (&lt; 100 ng/mL)</td><td rowspan=1 colspan=1>&lt;50% cutoffDevice Results (&lt; 100 ng/mL)</td><td rowspan=1 colspan=1>-50% to cutoff(100 ~ 199ng/mL)</td><td rowspan=1 colspan=1>cutoff to +50%(200 ~ 300ng/mL)</td><td rowspan=1 colspan=1>&gt;50% cutoff(&gt; 300 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>38</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>0</td></tr></table>

\*sample contained $1 8 7 \mathrm { n g / m L }$ Nordiazepam, which is equivalent to $2 0 7 . 8 ~ \mathrm { n g / m L }$ of Oxazepam (the calibrator drug).

$\%$ agreement among positives is $9 8 \%$ $\%$ agreement among negatives is $100 \%$ b. Matrix comparison: Not applicable.

3. Clinical studies: a. Clinical Sensitivity: Not applicable. b. Clinical specificity: Not applicable. c. Other clinical supportive data (when a. and b. are not applicable): Not applicable.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.